MicroRNAs

Glaucoma-Protective Human Single-Nucleotide Polymorphism in the Locus Increased ANGPT2 Expression and Schlemm Canal Area in Mice.

Kiyota N, Onay T, Leeaw P, et al. Glaucoma-Protective Human Single-Nucleotide Polymorphism in the Locus Increased ANGPT2 Expression and Schlemm Canal Area in Mice. Arteriosclerosis, thrombosis, and vascular biology. 2024. doi:10.1161/ATVBAHA.124.321555PubMed DOI Google Scholar

Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation.

Raghu A, Raghu A, Wise JF. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation. JMIR bioinformatics and biotechnology. 2024;5:e56538. doi:10.2196/56538PubMed DOI Google Scholar

Metabolite signatures associated with microRNA miR-143-3p serve as drivers of poor lung function trajectories in childhood asthma.

Mendez KM, Begum S, Tiwari A, et al. Metabolite signatures associated with microRNA miR-143-3p serve as drivers of poor lung function trajectories in childhood asthma. EBioMedicine. 2024;102:105025. doi:10.1016/j.ebiom.2024.105025Google Scholar PubMed DOI

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.

Korkut A, Zaidi S, Kanchi RS, et al. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Syst. 2018;7(4):422-437.e7. doi:10.1016/j.cels.2018.08.010PubMed DOI Google Scholar

High-throughput validation of ceRNA regulatory networks.

Chiu HS, Martínez MR, Bansal M, et al. High-throughput validation of ceRNA regulatory networks. BMC Genomics. 2017;18(1):418. doi:10.1186/s12864-017-3790-7PubMed DOI Google Scholar

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Robertson G, Kim J, Al-Ahmadie H, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2017;171(3):540-556.e25. doi:10.1016/j.cell.2017.09.007PubMed DOI Google Scholar

Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice.

Heyer MP, Pani AK, Smeyne RJ, Kenny PJ, Feng G. Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci. 2012;32(32):10887-94. doi:10.1523/JNEUROSCI.1732-12.2012PubMed DOI Google Scholar

NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.

Wang H, Pan JQ, Luo L, et al. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma. Mol Cancer. 2015;14:2. doi:10.1186/1476-4598-14-2PubMed DOI Google Scholar

miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.

Meyer SE, Muench DE, Rogers AM, et al. miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med. 2018;215(8):2115-2136. doi:10.1084/jem.20171312PubMed DOI Google Scholar

A Massively Parallel Reporter Assay of 3' UTR Sequences Identifies In Vivo Rules for mRNA Degradation.

Rabani M, Pieper L, Chew GL, Schier AF. A Massively Parallel Reporter Assay of 3’ UTR Sequences Identifies In Vivo Rules for mRNA Degradation. Mol Cell. 2017;68(6):1083-1094.e5. doi:10.1016/j.molcel.2017.11.014PubMed DOI Google Scholar